Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAS Blockade + Steroids for Proteinuria in IgA Nephropathy
NCT00367562Phase 4Completed
- Sponsor
- Hospital Británico de Buenos Aires
- Start
- Jan 1996
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of enalapril, valsartan and methylprednisolone in IgA nephropathy (IgAN), sponsored by Hospital Británico de Buenos Aires. Primary endpoint: Daily Proteinuria at 6 months. Started Jan 1996; status: completed.
02
Drugs
enalaprilvalsartanmethylprednisolone
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00367562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367562.